US Stock MarketDetailed Quotes

SCPH scPharmaceuticals

Watchlist
  • 3.290
  • -0.030-0.90%
Close Feb 26 16:00 ET
164.63MMarket Cap-1.69P/E (TTM)

scPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

scPharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.933M--
--2024/Q4-- / 12.076M--
Nov 13, 20242024/Q310.026M / 10.801M--
Aug 14, 20242024/Q28.054M / 7.970M--
May 14, 20242024/Q16.102M / 5.977M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.933M--
--2024/Q4-- / 12.076M--
Nov 13, 20242024/Q310.026M / 10.801M--
Aug 14, 20242024/Q28.054M / 7.970M--
May 14, 20242024/Q16.102M / 5.977M--

Unlock Free Earnings Estimates

scPharmaceuticals Earnings Reports

  • scPharmaceuticals | 10-Q/A: Quarterly report (Amendment)

    Dec 31, 2024 06:06 ET

  • scPharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 17:18 ET

  • scPharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 16:11 ET

  • scPharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 14, 2024 16:26 ET

    • Read more

    Trending Stocks
    Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

    Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

    Symbol Mini Chart % Chg
    Strategy
    MSTR
    +5.09%
    Meta Platforms
    META
    +2.46%
    Oracle
    ORCL
    +2.33%
    Amazon
    AMZN
    +0.73%
    Salesforce
    CRM
    +0.47%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 14, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data